-
Healthy Habits
Low-Effort EatsEating well during cancer treatment doesn't require a lot of work.
by Ashley P. Taylor
-
Forward Look
Investigating the Keto Diet’s Effects on CancerJocelyn Tan on what the studies show.
by Sue Rochman
-
The Coronavirus and Cancer Care
Cancer patients in the U.S. are feeling impacts from the new coronavirus.
by Kate Yandell
-
Forward Look
Clinical Trials Need Cancer Caregivers TooResearchers are studying how to best support family members.
by Delia O’Hara
-
Forward Look
Medicare to Cover CAR-T Cell TherapyHigh cost may still limit access.
by Nancy Averett
-
Despite Generic Imatinib, Cost of Treating CML Remains High
The arrival of generic versions of the targeted therapy imatinib only modestly reduced the cost of treating chronic myelogenous leukemia patients, a study finds.
by Anna Azvolinsky
-
From the Editor-in-Chief
Value-Based Cancer Care: Paying for PerformanceThe Centers for Medicare & Medicaid Services implements incentive programs to reward quality care.
by William G. Nelson, MD, PhD
-
Drinking After a Diagnosis
A study illuminates the alcohol consumption habits of cancer survivors.
by Jen Tota McGivney
-
Nothing but Time
A father with metastatic kidney cancer embraces moments with his 3-year-old son while pondering how he'll be remembered.
by Adam P. Stern
-
Forward Look
Treatment for Kids’ Brain Tumors Can Cause Hearing ProblemsSevere hearing loss may result in reading and learning difficulties.
by Esther Landhuis
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
